Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

MIND-FULNESS-BASED FAMILY RESILIENCE INTERVENTION FOR MOTHERS OF CHILDREN WITH INTELLECTUAL DISABILITIES

6 de septiembre de 2026 actualizado por: Filiz ER, Sinop University

STRENGTHENING FAMILY RESILIENCE THROUGH MINDFULNESS: A RANDOMIZED CONTROLLED MIXED-METHODS GROUP INTERVENTION WITH MOTHERS OF CHILDREN WITH INTELLECTUAL DISABILITIES

The goal of this clinical trial is to learn whether an eight-week Mindfulness-Based Family Resilience Group Intervention can improve family resilience and mindfulness in mothers of children with intellectual disabilities. The intervention combines mindfulness practices with principles from Walsh's systemic family resilience model.

The main questions it aims to answer are:

  • Does the intervention improve mothers' reported family resilience?
  • Does the intervention improve mothers' mindfulness?
  • How do mothers describe their caregiving experiences, parenting roles, and family life, and how do these experiences change during the intervention?

Researchers will compare mothers who receive the Mindfulness-Based Family Resilience Group Intervention with mothers in a control group who continue to receive usual care.

Participants in the intervention group will:

  • Attend one group session per week for eight weeks, with each session lasting approximately 90 minutes.
  • Take part in mindfulness practices and activities focused on awareness of thoughts, emotions, and bodily experiences, acceptance, self-compassion, and personal and family resources.
  • Complete assessments of family resilience and mindfulness before the intervention, after the intervention, and at a three-month follow-up.

Participants in the control group will continue to receive usual care and will complete the same assessments at the same time points.

The study will also examine participants' experiences during the group intervention to better understand the processes that accompany changes in family resilience and mindfulness.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

Mothers of children with intellectual disabilities may experience long-term caregiving demands that affect their emotional well-being, coping processes, and family life. Family resilience provides a systemic framework for understanding how families adapt to ongoing challenges by drawing on shared belief systems, organizational resources, communication, and problem-solving processes. Mindfulness, in turn, emphasizes present-moment awareness and a nonjudgmental approach to thoughts, emotions, and bodily experiences. Integrating these two approaches may provide a way to support both individual awareness and family-related coping resources.

The Mindfulness-Based Family Resilience Group Intervention was developed by integrating Walsh's systemic family resilience framework with core mindfulness principles and practices. The program was designed to help mothers become more aware of their thoughts, emotions, and bodily responses; relate to difficult experiences with greater acceptance and self-compassion; recognize automatic patterns of responding; and identify personal and family strengths and resources. Family resilience processes, including meaning-making, organizational patterns, communication, and problem solving, were addressed alongside mindfulness-based experiential practices.

The intervention consisted of eight weekly group sessions, each lasting approximately 90 minutes. Across the program, participants engaged in practices involving breath and body awareness, present-moment attention, nonjudgmental observation of thoughts and emotions, acceptance, self-compassion, emotion regulation, and reflection on personal and family resources. Experiential exercises and group discussions were used to connect mindfulness practices with participants' caregiving experiences, parenting roles, and family relationships.

The study used a randomized controlled, embedded mixed-methods design. The quantitative component was designed to evaluate changes in family resilience and mindfulness over time and to compare these changes between the intervention and usual-care control conditions. The qualitative component was embedded within the intervention process to provide a more detailed understanding of participants' experiences and the processes accompanying change.

Qualitative information obtained from group-session recordings and field notes was examined using thematic analysis. This component focused on how participants described and made sense of their caregiving experiences, difficult thoughts and emotions, parenting roles, personal and family resources, and changes experienced during the intervention. Integrating the quantitative and qualitative components was intended to provide a broader understanding of both changes in the measured outcomes and the experiential processes accompanying those changes.

Tipo de estudio

Intervencionista

Inscripción (Actual)

32

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • * Mothers of children aged 9-17 years.

    • Mothers whose children had mild or moderate intellectual disability.
    • Willingness to participate in the study and provide informed consent.

Exclusion Criteria:

  • Mothers whose children had severe intellectual disability.
  • Not meeting the predefined inclusion criteria.
  • Declining to participate in the study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Cuadruplicar

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Change in Family Resilience and Change in Mindfulness
Participants assigned to the experimental arm received the eight-week Mindfulness-Based Family Resilience Group Intervention. The intervention was delivered once weekly, with each group session lasting approximately 90 minutes. The program integrated Walsh's systemic family resilience framework with mindfulness-based practices, including breath and body awareness, nonjudgmental observation of thoughts and emotions, acceptance, self-compassion, emotion regulation, and activities aimed at identifying personal and family resources.
The Mindfulness-Based Family Resilience Group Intervention was an eight-week, group-based behavioral intervention integrating mindfulness practices with Walsh's systemic family resilience framework. The intervention was delivered once weekly, with each session lasting approximately 90 minutes. The eight sessions focused sequentially on: (1) building safety and awareness, (2) acceptance of emotions and self-compassion, (3) values and meaning-making, (4) acceptance of uncertainty, (5) flexible problem solving, (6) discovering family strengths, (7) consolidating gains and relapse prevention, and (8) integration and closure. Core mindfulness components included breath and body awareness, acceptance-based mindfulness, values-focused mindfulness, cognitive defusion and observing thoughts, strength-focused mindfulness, the three-minute breathing space, and compassion and gratitude meditation. Experiential and group activities were used to support emotional awareness, acceptance, psychological
Sin intervención: Control Group
Participants assigned to the control group continued to receive usual care during the study period and did not receive the Mindfulness-Based Family Resilience Group Intervention. They completed the same outcome assessments as the experimental group at baseline, post-intervention, and the three-month follow-up.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Family Resilience Scale (FRS)
Periodo de tiempo: Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Family resilience was assessed using the Family Resilience Scale (FRS), developed by Kaner and Bayraklı (2010). The scale consists of 37 items rated on a 5-point Likert scale ranging from 1 ("Does not describe me at all") to 5 ("Describes me very well"). Total scores range from 37 to 185, with higher scores indicating higher levels of family resilience. The scale includes four subscales: Resilience/Challenge (17 items), Self-Efficacy (9 items), Commitment to Life (8 items), and Control (3 items).
Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Mindful Attention Awareness Scale (MAAS)
Periodo de tiempo: Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS), developed by Brown and Ryan (2003). The scale consists of 15 items rated on a 6-point Likert scale ranging from 1 ("Almost always") to 6 ("Almost never"). Total scores range from 15 to 90, with higher scores indicating higher levels of mindful attention and awareness. The Turkish adaptation, validity, and reliability study of the scale was conducted by Özyeşil et al. (2011).
Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

13 de marzo de 2026

Finalización primaria (Actual)

1 de mayo de 2026

Finalización del estudio (Actual)

21 de julio de 2026

Fechas de registro del estudio

Enviado por primera vez

6 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

6 de septiembre de 2026

Publicado por primera vez (Actual)

14 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

14 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2025/613

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be made publicly available because of participant confidentiality and privacy considerations. The study included a relatively small sample and qualitative data derived from group-session recordings and field notes, which may increase the risk of participant identification even after de-identification. In addition, specific consent for public sharing of individual participant data was not obtained from participants. Aggregate study findings will be reported in scientific publications.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .